National Pension Service Raises Holdings in Cencora, Inc. $COR

National Pension Service increased its position in shares of Cencora, Inc. (NYSE:COR) by 2.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 677,729 shares of the company’s stock after purchasing an additional 15,355 shares during the period. National Pension Service’s holdings in Cencora were worth $211,811,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in COR. Cornerstone Wealth Management LLC bought a new stake in shares of Cencora in the 3rd quarter valued at about $225,000. AlphaQuest LLC bought a new position in shares of Cencora in the 3rd quarter worth $71,000. Knights of Columbus Asset Advisors LLC lifted its stake in shares of Cencora by 3.7% during the 3rd quarter. Knights of Columbus Asset Advisors LLC now owns 45,863 shares of the company’s stock worth $14,334,000 after purchasing an additional 1,654 shares during the last quarter. Cypress Capital Group lifted its stake in shares of Cencora by 4.4% during the 3rd quarter. Cypress Capital Group now owns 14,750 shares of the company’s stock worth $4,610,000 after purchasing an additional 619 shares during the last quarter. Finally, Ritter Daniher Financial Advisory LLC DE bought a new stake in Cencora during the third quarter valued at about $566,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Cencora

In other news, EVP Silvana Battaglia sold 1,677 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $345.00, for a total value of $578,565.00. Following the completion of the sale, the executive vice president directly owned 18,796 shares in the company, valued at $6,484,620. This represents a 8.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Elizabeth S. Campbell sold 3,351 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the transaction, the executive vice president owned 23,891 shares in the company, valued at $8,173,111.10. The trade was a 12.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 20,316 shares of company stock valued at $7,151,265 over the last ninety days. Insiders own 0.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Cencora in a research report on Monday, December 29th. TD Cowen boosted their target price on Cencora from $350.00 to $400.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Mizuho raised their price target on Cencora from $340.00 to $380.00 and gave the stock an “outperform” rating in a report on Thursday, November 6th. Wells Fargo & Company boosted their price target on Cencora from $354.00 to $405.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 11th. Finally, Jefferies Financial Group raised shares of Cencora from an “underperform” rating to a “buy” rating in a research report on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cencora has an average rating of “Moderate Buy” and an average target price of $393.08.

Cencora Price Performance

NYSE:COR opened at $359.14 on Friday. The firm has a market cap of $69.67 billion, a price-to-earnings ratio of 45.17, a PEG ratio of 1.68 and a beta of 0.66. Cencora, Inc. has a one year low of $237.71 and a one year high of $377.54. The firm’s fifty day moving average is $347.62 and its two-hundred day moving average is $324.08. The company has a debt-to-equity ratio of 4.32, a quick ratio of 0.55 and a current ratio of 0.90.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, November 5th. The company reported $3.84 EPS for the quarter, beating the consensus estimate of $3.79 by $0.05. Cencora had a net margin of 0.48% and a return on equity of 227.15%. The company had revenue of $83.73 billion for the quarter, compared to analyst estimates of $83.36 billion. During the same quarter last year, the business earned $3.34 earnings per share. The firm’s revenue was up 5.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. Research analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 1st. Shareholders of record on Friday, November 14th were paid a dividend of $0.60 per share. This is an increase from Cencora’s previous quarterly dividend of $0.55. The ex-dividend date was Friday, November 14th. This represents a $2.40 annualized dividend and a yield of 0.7%. Cencora’s dividend payout ratio (DPR) is presently 30.19%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.